We’re excited to share that Cilcare is featured in Forbes, with an article and video interview of 最高経営責任者（CEO） セリア・ベリーヌ, and Karine Lima.
The feature highlights our mission to address hearing loss as a major challenge for healthy aging, focusing on restoring auditory function from its earliest stages.
Cilcare’s lead program, CIL001, targets 蝸牛シナプス障害, a condition often undiagnosed, through a disease-modifying approach. We also leverage AI-driven patient stratification to identify the right patients in clinical trials, maximizing the potential for success.
It also highlights our journey from a Montpellier startup to an international biotech, our upcoming Phase 2 clinical trials, and strategic partnerships such as Shionogi, supporting the expansion of our pipeline and global reach.
Discover the Forbes article here: Soigner l’audition pour mieux vieillir : la stratégie de Cilcare – Forbes France
This recognition underscores Cilcare’s leadership in auditory science and commitment to improving hearing health worldwide.
